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ABSTRACT 47 
Merkel cell polyomavirus (MCV) small T antigen (sT) is the main oncoprotein for the 48 
development of Merkel cell carcinoma (MCC). MCC is a rare, clinically aggressive 49 
neuroendocrine tumor of the skin with a high propensity for local, regional, and distant spread. 50 
The dysregulation of matrix metalloproteinase-9 (MMP-9) has been implicated in multiple 51 
essential roles in the development of various malignant tumor cell invasion and metastasis. 52 
Previously, MCV sT was shown to induce the migratory and invasive phenotype of MCC cells 53 
through the transcriptional activation of the Sheddase molecule, ADAM 10 (A disintegrin and 54 
metalloprotease domain-containing protein 10). In this study, we show that MCV sT protein 55 
stimulates differential expression of epithelial–mesenchymal transition (EMT) associated genes, 56 
including MMP-9 and Snail. This effect is dependent on the presence of the large T stabilization 57 
domain (LSD), which is known to be responsible for cell transformation through targeting of 58 
promiscuous E3 ligases, including FBW7, a known MMP-9 and Snail regulator. Chemical 59 
treatments of MMP-9 markedly inhibited sT-induced cell migration and invasion. These results 60 
suggest that MCV sT contributes to the activation of MMP-9 as a result of FBW7 targeting, and 61 
increases the invasive potential of cells, which can be used for targeted therapeutic intervention.  62 
 63 
IMPORTANCE 64 
Merkel cell carcinoma (MCC) is the most aggressive cutaneous tumor without clearly defined 65 
treatment. Although MCC has a high propensity for metastasis, little is known about the underlying 66 
mechanisms that drive MCC invasion and metastatic progression. MMP-9 has shown to play a 67 
detrimental role in many metastatic human cancers, including melanoma and other non-melanoma 68 
skin cancers. Our study shows that MCV sT-mediated MMP-9 activation is driven through the 69 
LSD, a known E3 ligase targeting domain, in MCC. MMP-9 may serve as the biochemical culprit 70 
to target and develop a novel approach for the treatment of metastatic MCC.   71 
INTRODUCTION 72 
Merkel cell carcinoma (MCC) is a rare skin cancer of neuroendocrine origin with a high 73 
propensity to metastasize (1). Although the incidence rate of MCC is lower than melanoma, it is 74 
highly aggressive with an estimated mortality rate of 33%-46%; hence it is significantly more 75 
lethal than malignant melanoma (2). Merkel cell polyomavirus (MCV) is the etiological agent of 76 
MCC. The majority of MCC cases are associated with MCV as observed by monoclonal 77 
integration of the MCV genome in the tumor DNA (3). As a classic polyomavirus, the genomic 78 
organization of MCV is similar to other known human polyomaviruses. MCV expresses small 79 
and large tumor antigens (sT and LT), which are essential for viral replication and pathogenesis. 80 
MCC tumor-derived MCV LT sequences integrated into MCC genomes contain mutations 81 
prematurely truncating the C-terminal growth inhibitory domain (4), while MCV sT remains 82 
intact.  83 
 84 
MCV sT has been shown to mediate multiple oncogenic mechanisms that contribute to MCC 85 
development. Inhibition of SCF (Skp1, Cullin, F-box containing complex) E3 ligases by MCV 86 
sT appears to induce several viral and cellular oncoprotein activation, leading to enhanced MCV 87 
replication and cell proliferation (5, 6). Aberrant activation of oncogenic potential in MCV sT 88 
expressing cells also promoted the malignant phenotypes that are involved in genomic instability 89 
such as centrosome amplification, aneuploidy, and micronuclei formation (7). This oncogenic 90 
activity of MCV sT requires the LT stabilization domain (LSD), a unique and disordered domain 91 
of MCV sT, which is known to interact with SCF E3 ligase complexes (5, 7). Although the exact 92 
mechanism by which MCV sT targets E3 ligases is yet to be elucidated, it is clear that the LSD 93 
plays a significant role in the distinctive transforming activities induced by MCV sT in vitro and 94 
in vivo (5-7).  95 
 96 
The E3 ubiquitin ligase F-box and WD repeat domain containing 7 (FBW7) functions as a 97 
putative tumor suppressor and an evolutionarily conserved substrate receptor of SCF ubiquitin 98 
ligase complex and plays vital roles in cell proliferation and cell migration (8). In various 99 
cancers, including renal cancer (9, 10), gastric cancer (11) and hepatocellular carcinoma (12), 100 
FBW7 inhibition promotes metastasis and epithelial–mesenchymal transition (EMT) by 101 
upregulating matrix metalloproteinase expression, specifically MMP-2, MMP-9, and MMP-13. 102 
Matrix metalloproteinases (MMPs) are a zinc-dependent family of proteolytic enzymes that 103 
participate in the degradation of the extracellular matrix (ECM). Dysregulation of these proteases 104 
has been observed in multiple cancers where enhanced expression of certain MMP proteins 105 
contribute to cell migration, invasion, and angiogenesis (13, 14).  Specifically,  MMP-9 has been 106 
linked to multiple hallmarks of cancer, including but not limited to metastasis, invasion, 107 
immunological surveillance, and angiogenesis (15). MMP-9, also known as 92 kDa type IV 108 
collagenase (16), plays a vital role in the degradation of elastin and partially hydrolyzed collagen 109 
that is essential for maintaining epithelial structural integrity. Various studies have shown that 110 
human tumor virus-associated oncoproteins play a critical role in metastasis and EMT-related 111 
mechanisms.  Hepatitis B virus (HBV)-encoded X protein (HBx) (17), Kaposi’s sarcoma-112 
associated herpesvirus (KSHV) K1 (18), and Epstein-Barr virus (EBV) latent membrane protein 113 
1 (LMP-1) proteins (19) are known to upregulate MMP-9 expression, thereby contributing to 114 
invasiveness and metastasis, key hallmarks of cancer (20).  115 
 116 
MCV sT stimulates cell motility by inducing microtubule destabilization (21), actin 117 
rearrangement (22) and cell dissociation by disruption of cell junctions (23). Interrogation of 118 
previously published quantitative proteomic datasets of MCV sT-expressing cells indicates that 119 
MCV sT activated expression of Snail, a transcription factor that enhances mesenchymal genes, 120 
and MMP-9. In contrast, MCV sT significantly downregulated genes related to cell adhesion 121 
molecules, suggesting the potential function of MCV sT in the regulation of EMT.  MMP-9 and 122 
Snail activation by MCV sT was strictly dependent on the presence of the LSD, which resulted 123 
in the enhancement of cell migration in mouse fibroblast cells and human cancer cell lines. Our 124 
findings indicate that MCV sT targeting of cellular E3 ligases may play a role in MCV sT-125 
induced cell migration and invasion in MCC. Notably, chemical treatment with MMP-9 126 
inhibitors resulted in significant inhibition of MCV sT-induced cell migration and invasion. This 127 
suggests that MMP-9 protein may be a viable target for novel therapeutic intervention for 128 






MCV sT expression induces differential expression of proteins associated with EMT.  135 
Recent studies have highlighted the involvement of MCV sT in the highly migratory and cell 136 
dissociation phenotypes of MCC, elucidating its highly multifunctional roles in MCC (21-23). 137 
Previously described SILAC (stable isotope labeling by amino acids in cell culture)-based 138 
quantitative proteomics data (REF), was further interrogated to assess the alterations in the host 139 
cell proteome upon expression of MCV sT in a HEK293 derived cell line (i293-sT) (Fig. 1A) 140 
(21). These results highlighted an alteration in proteins associated with enhancement of cell 141 
migration (microtubule-associated cytoskeletal organization) and cell adhesion as previously 142 
reported and the basement membrane proteins, a specialized form of the ECM. Specifically, the 143 
quantitative proteomic analysis showed an almost two-fold decrease in Collagen alpha-2(IV) 144 
chain (COL4A2) and Laminin subunit gamma 1(LAMC1), two essential components of the 145 
basement membrane. The basement membrane is crucial for epithelial structural integrity. It is 146 
comprised of a network of glycoproteins and proteoglycans such as Type IV collagen and 147 
laminin and provides a barrier from invasion by tumor cells (24). These results suggest that 148 
MCV sT plays a role in the basement membrane degradation, an essential process for the 149 
metastatic invasion of tumor cells into the circulatory system to occur in MCC. Aligned with 150 
these observations, transcriptome analysis has suggested that specific markers associated with 151 
EMT are increased upon MCV sT expression (25).  152 
 153 
To validate the potential regulation of EMT-related markers by MCV sT, RT-qPCR was 154 
performed.  Changes in mRNA levels of classic EMT markers were assessed in MCC13 cells 155 
overexpressing a control of MCV sT construct. Upon MCV sT expression, a significant 156 
downregulation in epithelial markers E-cadherin, zonula occludens-1 (ZO-1) and Occludin was 157 
observed (Fig. 1B). Conversely, mesenchymal markers Slug, Snail, ZEB1, ZEB2, MMP-3, and 158 
MMP-9 were upregulated upon MCV sT expression. These results infer the possibility of MCV 159 
sT inducing an EMT, which contributes to the metastatic potential of MCV-associated MCC.  160 
 161 
MCV sT inhibition of FBW7 contributes to migratory phenotype.   162 
An essential requirement of metastasis involves the dissemination of tumor cells to various 163 
organs from the primary tumor (26).  Multiple studies have demonstrated that loss of FBW7 164 
promotes cell invasion and migration in numerous cancers through modulation of EMT-related 165 
cellular factors such as MMP-9 and Snail (27-29), which are upregulated transcriptionally upon 166 
MCV sT expression (Fig 1B).  The MCV sT LSD region is known to bind and inhibit the FBW7 167 
(5, 7).  As a result of this inhibition, FBW7 oncogenic substrates are stabilized in MCV sT-168 
expressing cells, which may contribute to MCV sT-induced migratory phenotype. Although 169 
MCV sT and FBW7 interaction has been characterized in vitro by co-immunoprecipitation in 170 
over-expressing cell, the in vitro techniques do not identify whether this interaction occurs with 171 
endogenous proteins and , therefore, may not reflect the native behavior of their endogenous 172 
counterparts. Proximity ligation assay (PLA) can detect interactions with high specificity and 173 
sensitivity due to the coupling of antibody recognition and DNA amplification, which provides a 174 
technical advantage over other protein-protein interaction assays often plagued with long 175 
preparation times and extensive troubleshooting. For that reason, we utilized PLA combined with 176 
flow cytometry to revalidate this interaction (30, 31). As shown in Fig. 2A, quantification of 177 
wild-type MCV sT interaction with FBW7 resulted in high-intensity PLA signal comparative to 178 
our positive control c-Myc, a well-known FBW7 substrate (32). This interaction was markedly 179 
diminished by expression of sTLSDm (Fig. 2A), an LSD alanine mutant of MCV sT, consistent 180 
with the finding from a previous report (5). 181 
 182 
To determine whether MCV sT targeting of FBW7 contributes to sT-induced migratory 183 
phenotype, a scratch assay was performed comparing vector control, MCV sTWT, and MCV 184 
sTLSDm  in U2OS cells. Images of the scratch area were recorded at time point 0 and 24 h post 185 
scratch. Compared to empty vector negative control, MCV sT greatly enhanced the motility and 186 
migration of U2OS cells, consistent with previous studies (Fig. 2B)  (21-23, 33).  In contrast, 187 
MCV sTLSDm did not show a significant increase in cell migration. Over the 24 h period of the 188 
assay, we see no significant positive or negative effect on cell number confirmed by a viability 189 
assay, indicating that the resulting phenotype is specific to cell migration (Fig. 2B). Similarly, 190 
enhanced cell migration was readily detected with wild-type sT in NIH3T3 mouse fibroblast 191 
(Fig. 2C) and MCC13 (MCV negative MCC cell line) (Fig. S1B), while this phenotype is not 192 
induced by sTLSDm. This suggests that sT targeting of FBW7 may be involved in the MCV sT-193 
induced cell migratory phenotype.  194 
 195 
MCV sT inhibition of FBW7 prevents turnover of MMP-9.  196 
As shown in Fig. 1B, MCV sT induces MMP-9, an essential protein associated with the FBW7-197 
EMT axis in human cancers (34). To confirm MCV sT induction of MMP-9 expression, a variety 198 
of cell lines, 293, COS-7, MCC13, and U2OS cells were transfected with a vector control and 199 
MCV sT plasmids. MMP-9 gene expression is primarily regulated transcriptionally, resulting in 200 
low basal levels of these proteases in normal physiology (35). RT-qPCR results showed that 201 
MCV sT expression significantly increased MMP-9 transcript levels in all cell lines tested (Fig 202 
3A). 203 
 204 
We posited that MCV sT targeting of FBW7 plays a role in promoting the migratory potential of 205 
MCC by preventing MMP-9 protein turnover. Both transcriptional and post-transcriptional levels 206 
of MMP-9 were assessed in the presence of the MCV sTWT or MCV sTLSDm in U2OS and 207 
MCC13 cell lines. Results showed that MCV sT significantly induced the upregulation of MMP-208 
9 transcripts when analyzed by RT-qPCR in both cell lines, which was not observed upon 209 
mutation of the MCV sT LSD (Fig 3B). Additionally, we performed immunoblot analysis to 210 
evaluate the effect of sT on MMP-9 protein levels. Studies have shown MMP-9 exists in several 211 
forms; a monomeric pro- (∼92 kDa), a disulfide-bonded homodimeric (∼220 kDa) and multiple 212 
active forms (∼67 and 82 kDa) (36). The active and dimeric forms of MMP-9 play a role in the 213 
invasive and migratory phenotypes of cancer cells (37, 38). Our results demonstrated a 214 
significant increase in MMP-9 mature protein levels upon MCV sT expression. MCV sTWT 215 
expression induced the upregulation of the dimer, monomer, and active forms of MMP-9. 216 
However, mutation of the LSD prevented MCV sT-mediated upregulation of MMP-9 as 217 
expression levels remained comparable with the control, suggesting that MCV sT-mediated 218 
upregulation of MMP-9 is LSD-dependent (Fig 3C and 2D).    219 
 220 
MMP-9 inhibition impedes MCV sT-induced cell migration.  221 
We next sought to determine if MMP-9 inhibition would have an impact on MCV sT induced 222 
motile and migratory potentials. The migratory phenotype of U2OS cells transfected with vector 223 
control, sTWT and sTLSDm was assessed using a scratch assay in the absence or presence of non-224 
cytotoxic concentrations of MMP9-I and MMP9-II inhibitors (Fig. S2A). MMP-9 inhibition 225 
resulted in a significant decrease in the distance traveled by MCV sT expressing cells (Fig. 4A 226 
and 4B), confirming that the MMP-9 is a critical migratory factor that is regulated by MCV sT. 227 
Incubation of both inhibitors showed a slight decrease in the motility of vector control cells, 228 
implying that any changes observed in migratory rates of MCV sT expression cells are not due to 229 
changes in cell viability or cytotoxicity. Both inhibitors showed a minor impact on the motility of 230 
sTLSDm expressing cells, comparable to vector control cells.  231 
 232 
MMP-9 is essential for cell motility and migration in MCC. 233 
To demonstrate that MMP-9 is vital for cell motility and migration in metastatic MCC, a 234 
transwell migration assay was performed using MCV-positive MCC cell lines. This assay 235 
quantified the migration ability of MCC cells towards a chemoattractant across a permeable 236 
chamber. MCV-positive MCC cell lines, MKL-1 and MS-1, were incubated in the absence or 237 
presence of the MMP9-I and MMP9-II inhibitors at non-toxic concentrations (Fig. S2B, C). 238 
After treatment, cells were allowed to migrate for 48 h and the total numbers of migrated cells 239 
were measured by cell counting Kit-8 assay. Results showed the migration of MCV-positive 240 
MCC cell lines was significantly reduced (~40 to 50%) upon incubation of both MMP-9 241 
inhibitors in comparison to the untreated control, suggesting that MMP-9 expression contributes 242 
to the migratory capacity of MCV-positive MCC (Fig. 4C). Together, these results indicate that 243 
MMP-9 is required for MCV sT-mediated cell migration enhancement in MCC. 244 
 245 
MCV sT invasive phenotype is LSD-dependent.  246 
The invasiveness of epithelial cancers is a multi-step process and a key hallmark involves the 247 
degradation of the basement membrane. Type IV collagen is a major component in most 248 
basement membranes. Multiple studies have correlated overexpression of MMPs with not only 249 
an enhancement of cell migration and metastasis, but also the invasiveness of cancer cells (13, 250 
15). In particular, MMP-9 is a key protease associated with the degradation of ECM components, 251 
including type IV collagen and laminin, which in turn facilitates invasion of tumors into the 252 
circulatory system and promotes metastasis. To test if enzymatic activation of MMP-9 is 253 
regulated by sT LSD, we evaluated the effect of MCV sT on MMP-9 substrate collagen IV, by 254 
immunofluorescence staining in U2OS cells. Our results demonstrate that collagen IV expression 255 
in MCV sTWT expressing cells is significantly reduced in comparison to vector control cells, 256 
potentially due to MMP-9 activation induced by MCV sT. In contrast, MCV sTLSDm expressing 257 
cells did not show a decrease in collagen IV expression (Fig. 5A, Fig. S3).  Moreover, our 258 
regression analysis revealed that collagen IV expression levels are highly correlated with MCV 259 
sTWT or sTLSDm expression levels (Fig. 5B). To further validate the effect of MCV sT LSD on 260 
collagen IV degradation, we performed an invasion assay using collagen pre-coated inserts in 261 
U2OS and MCC13 cells. sTWT induced 4 to 5-fold increases in collagen invasion compared to 262 
either vector control or sTLSDm (Fig. 5C), inferring that MCV sT induces not only cell migration, 263 
but also cancer cell invasion through the LSD.  264 
 265 
MCV sT activates expression of EMT regulator, Snail.  266 
A positive regulatory loop has been identified between MMP-9 and Snail. siRNA mediated 267 
inhibition of MMP‐9 significantly reduces expression of Snail, and conversely, knockdown of 268 
Snail, a transcription factor of MMP-9, suppresses expression of MMP‐9 (39). FBW7 abrogation 269 
of Snail protein also inhibits MMP-9 expression (40).  Interestingly, MCV sT induced Snail 270 
expression in our initial transcriptional analysis (Fig. 1B). Since both MMP-9 and Snail are vital 271 
mediators of EMT, we assessed the effect of sT LSD on transcriptional and protein levels of 272 
Snail in U2OS cells. RT-qPCR results showed that MCV sTWT upregulated  mRNA levels of 273 
Snail, while this transcriptional change was not observed upon mutation of the LSD (Fig. 6A). 274 
Similar to RT-qPCR data, our results demonstrated a significant increase in Snail protein levels 275 
upon MCV sT expression in an LSD-dependent manner (Fig. 6B).   276 
 277 
DISCUSSION  278 
 279 
Metastasis is the endpoint of a series of biological processes by which a tumor cell detaches from 280 
the primary tumor and disseminates to a distant site through the circulatory system and 281 
establishes a secondary tumor (41). Oncogenic viruses often modulate the EMT axis via 282 
regulating E-cadherin repression (42-44), fibroblast growth factor (FGF) ligand modulation (44, 283 
45), cadherin switching (46, 47), induction of transcription factors such as TWIST (48, 49) and 284 
Snail (42, 50), and  MMP-9 upregulation (17-19). These cellular targets can regulate cancer cell 285 
migration and invasion; therefore, they could be exploited for therapeutic strategies in virus-286 
induced metastatic cancers.  287 
 288 
Multiple F box proteins can function as tumor suppressors by negatively regulating oncoproteins, 289 
and various studies have focused on elucidating this mechanism in tumorigenesis and EMT 290 
progression (34). In this report, we show that MCV sT LSD inhibition of FBW7 promotes the 291 
upregulation of MMP-9 and contributes to MCV sT-mediated cell migration and invasion. The 292 
mechanism by which FBW7 regulates MMP-9 expression is currently unclear, although many 293 
studies have shown MMP-9 expression is directly and indirectly regulated by FBW7 substrates 294 
such as XBP1, Notch1, and Snail (12, 40, 51). Snail is known to be a substrate of both FBW7 295 
(40) and -TrCP (52), another major SCF E3 ligase that MCV sT targets through the LSD (7). 296 
As previously shown, Snail gene expression induces the loss of epithelial markers and the gain of 297 
mesenchymal markers, as well as promoting changes in cell motility and invasive properties 298 
(53).  Our study initially focused on an MMP-9 specific metastatic progression induced by MCV 299 
sT due to limited availability of Snail inhibitors. However, the distressed proteome balance in 300 
EMT molecules induced by MCV sT might be triggered by Snail activation through MCV sT 301 
targeting multiple E3 ligases, which requires further investigation.  302 
 303 
While the detailed regulatory mechanisms and specificity of sT function in transcription 304 
modulation remain unclear, studies have shown that MCV sT mediates cellular 305 
transcriptome/chromatin remodeling (25, 54) which may alter transcriptional activity and gene 306 
expression. Consistent with our data, Berrios et al. also reported that MCV sT downregulates 307 
extracellular matrix organization and cell adhesion molecules in their transcriptome analysis 308 
(25). We have demonstrated that MCV sT specifically activates both mRNA and protein levels 309 
of the EMT-related cellular proteins MMP-9 and Snail through the LSD; however, our results do 310 
not rule out the possibility that this effect is potentially modulated by multiple mechanisms in 311 
MCC. Nonetheless, it is clear that MCV sT LSD plays a critical role in regulating metastasis-312 
initiating capacity in MCC that could be a potential target for therapeutic interventions. 313 
The underlying mechanism for the high propensity of MCC tumors to metastasize is yet to be 314 
elucidated. Because of the rare and aggressive nature of metastatic MCC and the lack of standard 315 
chemotherapy, there are no prospective studies of outcomes following treatment of distant 316 
metastatic MCC. Since recent FDA approvals of Avelumab and Pembrolizumab represent the 317 
only approved treatment option for metastatic MCC (55, 56), it is necessary to evaluate the 318 
preclinical anticancer activity of efficient and economical chemotherapeutics through 319 
retrospective analysis for both MCV-negative and positive MCC patients. MCV-negative MCC 320 
tumors patients are more likely to present with advanced disease than patients with virus-positive 321 
tumors (66.7% vs. 48.3%) (57). However, targeting the signaling pathways implicated in 322 
regulating tumor invasion could be an effective therapeutic protocol for both types of metastatic 323 
MCC treatment.  324 
Our study is the first approach to investigate the therapeutic potential of matrix metalloproteinase 325 
in MCC. MCV sT specifically activates the EMT-related cellular proteins MMP-9 through the 326 
LSD, which we targeted by commercially available inhibitors, and revealed a potential secondary 327 
treatment for distant metastatic MCC.  328 
 329 
MATERIALS AND METHODS 330 
Cells. 293, U2OS, and COS-7 cells were maintained in Dulbecco's modified Eagle's medium 331 
(DMEM) containing 10% fetal bovine serum (FBS) (Seradigm).  MCC13, MS-1, and  MKL-1 332 
cell lines were maintained in RPMI 1640 medium supplemented with 10% FBS (Seradigm).  333 
NIH3T3 cells were maintained in DMEM with 10% bovine calf serum (Seradigm). 334 
 335 
Plasmids, transfection and transduction. Plasmids for vector control, codon-optimized cDNA 336 
constructs for sTWT and sTLSDm have been previously described (5). HA-Fbw7 and Flag-cMyc (32) 337 
plasmids were kindly provided by Dr. Nakayama (Kyushu University, Japan).  FBW7ΔDF(d231-338 
324) was generated by overlapping PCR using primers listed in Table S2. For sT protein 339 
expression, cells were transfected using Lipofectamine 3000 (Invitrogen) or jetOPTIMUS 340 
(Polyplus Transfection) according to the manufacturer’s protocol. For lentiviral transduction, 341 
codon-optimized cDNAs for MCV sTWT, MCV sTLSDm, (5) and H-RasV12 were inserted into 342 
pLVX empty vector. Plasmids used for this study were listed in Table S1. For lentivirus 343 
production, 293FT (Invitrogen) cells were used for induction according to the manufacturer’s 344 
instructions. Cells were selected with puromycin (3 µg/ml) after infection for one week.  345 
 346 
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR).  RNA was 347 
extracted using Monarch Total RNA miniprep kit (New England Biolabs), as per the 348 
manufacturer’s instruction. 250 ng of RNA was used as a template in each reaction with iTaq 349 
Universal One-Step RT-qPCR Kit (Bio-Rad) or Luna Universal One-Step RT-qPCR Kit (New 350 
England Biolabs). Primer sequences used are described in Table S2. With GAPDH as an internal 351 
control, quantitative analysis was performed using the comparative ΔΔCt method.  352 
 353 
Quantitative immunoblotting (IB) and antibodies. Cells were lysed in IP buffer (50 mM Tris-354 
HCl (pH 8.0), 150 mM NaCl, 1% TritonX-100, 1 mM PMSF, 1 mM benzamidine) and sonicated 355 
whole cell lysates were used for direct immunoblotting. Primary antibodies were incubated 356 
overnight at 4°C, followed by 1 h secondary antibody incubation at RT. All signals were 357 
detected using quantitative Infrared (IR) secondary antibodies (IRDye 800CW goat anti-mouse, 358 
800CW goat anti-rabbit, 680LT goat anti-rabbit IgG, 680LT goat anti-mouse IgG) (LI-COR).  359 
Signal intensities were analyzed using a laser-scanning imaging system, Odyssey CLX (LI-360 
COR). Antibodies used for this study are listed in Table S3. Protein levels were quantitated and 361 
normalized by control, α-Tubulin, or -Actin, using an Odyssey LI-COR IR imaging system.  362 
 363 
SILAC data analysis.  The previously published SILAC-based quantitative proteomic data set 364 
analyzing host cell proteome changes upon MCV sT expression (REF) was deposited in the X 365 
with the identifier number X and further interrogated using the Database for Annotation, 366 
Visualization and Integrated Discovery (DAVID) v6.7 (51). For quantitative analysis, a 2.0-fold 367 
cutoff was chosen as a basis for investigating potential proteome changes (50).  368 
 369 
Proximity ligation assay (PLA) Flow cytometry. PLA was performed using a Duolink assay 370 
kit (Sigma-Aldrich) according to the manufacturer's instructions. To evaluate MCV sT and 371 
FBW7 interaction, HA-FBW7ΔDF(d231-324) was co-expressed with sTWT or sTLSDm. 372 
FBW7ΔDF was also co-expressed with c-Myc, a known FBW7 substrate, as a positive control 373 
(32). Primary antibodies were utilized at optimized concentrations with HA-Tag (C29F4) 374 
(1:500), c-Myc (9E10) (1:500), and 2T2 (1:500) (Millipore). Cells were analyzed by flow 375 
cytometry on a 16-color BD LSR Fortessa. The acquired data were analyzed using FlowJo 376 
software (Tree Star, Ashland, OR, USA). 377 
Scratch wound-healing assay. Cells were seeded into the Poly-L-Lysine-coated 6-well plates 378 
and transfected with either empty vector or sTWT or sTLSDm plasmids. Because MCV sT promotes 379 
serum-independent cell growth (58), a serum starvation condition was not considered for our 380 
scratch assay to exclude cell proliferation effect by sT. After 48 h, a scratch was created by 381 
scraping the monolayer using a p1000 pipette tip. The migration of cells toward the scratch was 382 
observed over a 24 h period, and images were taken every 8 h under a REVOLVE4 fluorescent 383 
microscope (Echo Laboratories). Inhibitor-based scratch assays were incubated for 24 h prior to 384 
transfection with 0.1 and 1 μM of 9-I and 9-II inhibitors respectively.  385 
 386 
Transwell cell migration assay. Cells grown in DMEM with 10% FBS were trypsinized and 387 
resuspended in DMEM. 1 × 105 cells were gently added to the transwell insert (8 m, Greiner 388 
Bio-One). DMEM with 10% FBS was added to the bottom of the lower chamber (24-well plate). 389 
The cells were incubated in the culture incubator at 37 °C plus 5% CO2 for the indicated time. 390 
The cells migrated from the insert to the well through the filter. The filter was fixed with 4% 391 
paraformaldehyde in PBS for 10 min, then stained with 1% Crystal Violet in 2% ethanol for 20 392 
min for NIH3T3 cells and MCC cells were counted using a Cell Counting Kit-8 (CCK-8) 393 
(Sigma-Aldrich). The stained cells on the lower side were counted under a microscope from 5 394 
different randomly selected views. All conditions were the same for assays performed in 395 
triplicate.  396 
 397 
Immunofluorescence. U2OS cells grown on glass coverslips were transfected with empty vector 398 
or sT wild type or LSD mutant expression constructs. After 48 h, cells were fixed in 1:1 399 
methanol/acetone at -20oC, permeabilized, and blocked in PBS with 5% BSA and 0.3 M glycine 400 
for 1 h. Cells were labeled with the appropriate primary antibodies and then incubated with the 401 
appropriate Alexa Fluor-conjugated secondary antibody. Cells were analyzed with a 402 
REVOLVE4 fluorescent microscope (Echo Laboratories).  403 
 404 
Collagen invasion assay.  U2OS and MCC13 cells were transfected with wild-type and LSD 405 
mutant sT constructs for 48 h, followed by overnight serum starvation. 1 x10^6 cells 406 
resuspending in serum-free media in each condition were seeded in a 24-well cell invasion plate 407 
containing polymerized collagen-coated membrane inserts. The collagen inserts had a  pore size 408 
of 8 μm (Chemicon QCM Collagen Cell Invasion Assay, ECM551). Complete medium was used 409 
as a chemoattractant in the lower chamber and cells were left to incubate for 72 h. Cells/media 410 
were carefully aspirated by pipetting any residual suspension in the transwell insert.  Inserts were 411 
transferred to a clean well and were carefully stained with 400 μL cell staining solution at room 412 
temperature for 20 minutes, followed by a gentle wash in deionized water. While slightly damp, 413 
unattached cells were removed cautiously by cotton swabs from the collagen inserts and allowed 414 
to dry at room temperature for 15 minutes. Dried inserts were transferred to clean wells 415 
containing 200 μL of extraction buffer and incubated for 15 minutes at room temperature. 416 
Following the extraction incubation, 100 μL of the extraction solution was pipetted into 96 well 417 
plates, and optical density was measured at 560 nm.  418 
 419 
Cell Proliferation Assay. U2OS transfected cells (vector control, MCV sTWT and MCV sTLSDm 420 
plasmids) were seeded in 96 well plates  (1 × 104 cells/well) 48 h post-transfection. Cell 421 
proliferation was monitored using a WST-8 based assay Cell Counting Kit-8 (CCK-8) according 422 
to the manufacturer’s protocol.  OD values were divided by the OD value of day 0 for 423 
normalization. 424 
 425 
Chemical inhibitors.  MMP-9 inhibitors-I and II (EMD Millipore) were used at 0.1 to 0.2 μM 426 
and 1 to 2 μM, respectively. Cell toxicity was measured using a Cell Counting Kit-8 (CCK-8) 427 
(Sigma-Aldrich) according to the manufacturer’s protocol.  428 
 429 
Statistical analysis.  Statistical significance between two groups was determined using one- or 430 
two-tailed student’s t-tests in GraphPad Prism (GraphPad Software, Inc., La Jolla, CA, USA). 431 
The difference was considered significant when p < 0.05 for multiple testing.  *, **, *** = p-432 
value < 0.01, 0.005 and 0.001, respectively.  433 
 434 
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FIGURE LEGENDS 623 
FIGURE 1 624 
MCV sT leads to differential expression of proteins associated with epithelial to 625 
mesenchymal transition (EMT). (A) Quantitative proteomics analysis illustrating differential 626 
expression of EMT associated proteins upon MCV sT expression. Proteins associated with cell 627 
adhesion and structural integrity of the extracellular matrix are downregulated upon MCV sT 628 
expression. While expression of proteins which encourage cell migration by reorganization of 629 
the actin network and microtubule destabilization are upregulated. (B) MCV sT regulates EMT-630 
associated gene expression. MCC13 cells were transfected with control or MCV sT expression 631 
plasmids. While epithelial markers were downregulated, mesenchymal markers were 632 
significantly upregulated upon MCV sT expression. Cellular RNA was extracted using a trizol 633 
reagent and transcript levels were analyzed by RT-qPCR using the comparative ΔΔCt method (n 634 
= 3).  635 
FIGURE 2 636 
MCV sT induces cell motility in an LSD-dependent manner. (A) Validation of MCV sT and 637 
FBW7 interaction. To confirm the interaction of  HA-FBW7 and MCV sT LSD domain, a PLA-638 
flow cytometric analysis was carried out. Wild-type MCV sT displayed an interaction with 639 
FBW7 comparative to the positive control interaction of c-Myc with FBW7, while mutation of 640 
sT LSD greatly ablated sT interaction with FBW7. Primary antibodies were utilized at optimized 641 
concentrations with HA-Tag (C29F4) (1:500), c-Myc (9E10) (1:500), and 2T2 (1:500). Protein 642 
expression was evaluated by immunoblot analysis in Fig. S1A. (B) MCV sT induced-cell 643 
migration is LSD-dependent. Scratch assay. Poly-L-lysine-coated 6-well plates were seeded with 644 
U2OS cells and transfected with either a vector control, sTWT and sTLSDm (Fbw7 binding mutant) 645 
plasmids. Migration of cells toward the scratch was observed over a 24 h period, and images 646 
were taken using a REVOLVE4 fluorescent microscope (Echo Laboratories).  Scratch assays 647 
were performed in triplicate and measured using Fiji Image J analysis software.  Differences 648 
between means (p value) were analyzed using a t-test with GraphPad Prism software. Protein 649 
expression was detected by immunoblot analysis to validate successful transfection using 2T2 650 
antibody for sT antigens and -Tubulin, respectively. No significant differences in cell 651 
proliferation were observed between cells expressing MCV sT within 24 h, indicating that cell 652 
proliferation does not interfere with the measurement of sT- induced cell migration. (C) MCV sT 653 
promotes rodent fibroblast cell migration. NIH3T3 cells stably expressing an empty vector, H-654 
RasV12, sTWT and sTLSDm were trypsinized and 2x10
5 cells were used for transwell migration 655 
and scratch assay. H-RasV12 was used as a positive control. The experiments were performed 656 
two times, and the results were reproducible. The graph indicates the fold difference of migrated 657 
cells relative to the vector control sample.  Protein expression was determined by 658 
immunoblotting. 659 
FIGURE 3 660 
MCV sT activates Matrix metalloproteinase 9 (MMP-9). (A) MCV sT expression results in 661 
upregulation of MMP-9 mRNA levels. Various cell lines (293, COS-7, MCC13 and U2OS) were 662 
transfected with either empty vector or MCV sTWT expressing plasmids to measure MMP-9 663 
mRNA levels. After 48 h, total RNA was isolated and analyzed by RT-qPCR. (B) MCV sT 664 
upregulates MMP-9 transcription through the LSD. U2OS and MCC13 cells transfected with 665 
empty vector control, MCV sTWT and MCV sTLSDm expressing plasmids. Transcript levels of 666 
MMP-9 were analyzed using the comparative ΔΔCt method. (n = 3). Differences between means 667 
(p value) were analyzed using a t-test with GraphPad Prism software. (C) MCV sT upregulates 668 
MMP-9 protein expression through the LSD. U2OS cells were transfected with empty vector, 669 
sTWT and sTLSDm expression plasmids. After 48 h, immunoblot analysis was performed to 670 
analyze expression of MMP-9, sT and -tubulin (Ci). Densitometry quantification of 671 
immunoblots was carried out using the Image studio software and is shown as a fold change 672 
relative to the loading control -tubulin (Cii). Data analyzed using three biological replicates per 673 
experiment (n = 3). (D) MCV sT reproducibly activates MMP-9 expression in MCC13. 674 
FIGURE 4 675 
MMP-9 inhibition impedes MCV sT-induced cell migration. (A) MCV sT promotes MMP-9-676 
induced cell migration. Scratch assay. Poly-L-lysine-coated 6-well plates were seeded with 677 
U2OS cells and incubated with specific MMP-9 inhibitors at predetermined concentrations. Cells 678 
were transfected with either a vector control, sTWT and sTLSDm plasmids. After 48 h, a scratch 679 
was created and migration of cells toward the scratch was observed over a 24 h period. The size 680 
of the wound was measured at 0 and 24 h and presented as the fold change in (B). Scratch assays 681 
were performed in triplicate. (C) MMP-9 is required for MCC migration. MCV positive MCC 682 
cell lines, MKL-1 and MS-1, were incubated with DMSO or the MMP-9 inhibitors 9-I (0.2 μM) 683 
and 9-II (2 μM); 9-I (0.1 μM) and 9-II (1 μM), respectively. Cells were then transferred into 684 
transwell inserts and allowed to migrate for 48 h. Migrated cells were measured using cell 685 
counting kit-8 (CCK-8). Data analyzed using three biological replicates per experiment, n = 3. 686 
Differences between means (p value) were analyzed using a t-test with GraphPad Prism 687 
software. 688 
FIGURE 5 689 
MCV sT LSD induces collagen degradation. (A) MCV sT decreases collagen IV expression. 690 
U2OS cells were transfected with empty vector control, MCV sTWT and MCV sTLSDm plasmids. 691 
Cells were fixed at 48 h post transfection and endogenous collagen IV levels were measured by 692 
indirect immunofluorescence using a specific antibody. MCV sT expression was detected with 693 
2T2 antigen antibody. Nuclear counterstain (DAPI-Blue), MCV sTWT and MCV sTLSDm (Green), 694 
and collagen IV(Red). (B) sT regulates collagen IV expression through the LSD. Mean 695 
Florescence intensity of collagen IV in wildtype (Bi) and LSD mutant sT-expressing cells (Bii) 696 
was analyzed using Fiji Image J software. The calculated values were plotted for regression 697 
analysis using Prism software (C) sT induces cell invasion through the LSD. (Ci) Collagen 698 
invasion assay. Serum starved sT-expressing U2OS cell were seeded on the precoated collagen 699 
inserts and incubated for 72 h, then labeled with a cell staining solution for 20 min. Upon 700 
extraction of the cell staining solution, absorbance at OD560 was measured. Data analyzed using 701 
three replicates per experiment; the experiments were performed two times. The results were 702 
reproducible and differences between means (p value) were analyzed using a t-test with 703 
GraphPad Prism software. (Cii) Expression of sT. Protein expression levels of wild type and 704 
mutant MCV sT were detected by immunoblot analysis to validate successful transfection. 705 
Quantitative infrared fluorescence immunoblotting was performed using a 2T2 antibody for sT 706 
antigens and -Tubulin as an equal loading control. 707 
FIGURE 6 708 
MCV sT LSD induces Snail expression. (A) MCV sT activates the transcription of Snail in an 709 
LSD-dependent manner. U2OS cells were transfected with empty vector control, sTWT and 710 
sTLSDm expressing plasmids. Cellular RNA was extracted at 48 h post transfection and transcript 711 
levels were analyzed using the comparative ΔΔCt method (n = 3). (B)  Snail protein expression 712 
is induced by MCV sT through the LSD. Immunoblot analysis was performed on the cellular 713 
lysates and analyzed using Snail specific antibody. -Tubulin was used as a measure of equal 714 
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